Tiagabine (Epilepsy = All indications) updated on 04-22-2025

All congenital malformations (majors, minors, majors and minors, or unspecified)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S7798
R35194
Vajda (Tiagabine) (Controls exposed to Lamotrigine, sick) , 2019 Fetal malformations at least 1st trimester prospective cohort exposed to other treatment, sick excluded Adjustment: No 18.80 [0.36;971.86] C
excluded (control group)
0/1   20/406 20 1
ref
S7800
R35193
Vajda (Tiagabine) (Controls unexposed, sick), 2019 Fetal malformations at least 1st trimester prospective cohort unexposed, sick Adjustment: No 31.00 [0.56;1711.11] C 0/1   5/176 5 1
ref
Total 1 studies 31.00 [0.56;1711.11] 5 1
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Vajda (Tiagabine) (Controls unexposed, sick), 2019Vajda, 2019 1 31.00[0.56; 1711.11]510%ROB confusion: criticalROB selection: moderateROB classification: lowROB missing: moderateROB mesure: moderateROB reporting: moderate0.9100.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Tiagabine) (Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 31.00[0.56; 1711.11]51 -NAVajda (Tiagabine) (Controls unexposed, sick), 2019 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 31.00[0.56; 1711.11]51 -NAVajda (Tiagabine) (Controls unexposed, sick), 2019 1 Tags Adjustment   - No  - No 31.00[0.56; 1711.11]51 -NAVajda (Tiagabine) (Controls unexposed, sick), 2019 1 All studiesAll studies 31.00[0.56; 1711.11]51 -NAVajda (Tiagabine) (Controls unexposed, sick), 2019 10.5100.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 7798

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed, sick controlsunexposed, sick controls Out of scale31.00[0.56; 1711.11]51 -NAVajda (Tiagabine) (Controls unexposed, sick), 2019 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls Out of scale18.80[0.36; 971.86]201 -NAVajda (Tiagabine) (Controls exposed to Lamotrigine, sick) , 2019 10.510.01.0